This action might not be possible to undo. Are you sure you want to continue?
Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study
AH Aamodt, LJ Stovner, K Hagen & J-A Zwart
Norwegian National Headache Centre, Trondheim University Hospital, Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Norway
Aamodt AH, Stovner LJ, Hagen K & Zwart J-A. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 2008; 28:144– 151. London. ISSN 0333-1024 Associations between headache, including migraine, and gastrointestinal (GI) symptoms were studied in a large questionnaire-based cross-sectional study (the Head-HUNT Study). The headache questionnaire was completed by 43 782 individuals, who answered all the questions concerning nausea, reﬂux symptoms, diarrhoea and constipation. In the multivariate analyses, adjusting for age, sex, educational level, medication use, depression and anxiety, a higher prevalence of headache was found in individuals with much reﬂux [odds ratio (OR) 2.4, 95% conﬁdence interval (CI) 2.2, 2.6], diarrhoea (OR 2.4, 95% CI 2.1, 2.8), constipation (OR 2.1, 95% CI 1.9, 2.4) and nausea (OR 3.2, 95% CI 2.6, 3.8) compared with those without such complaints. All the GI symptoms investigated seemed to be approximately as common among persons with non-migrainous headache as among migraine sufferers, but the association between headache and GI complaints increased markedly with increasing headache frequency. This may suggest that headache sufferers generally are predisposed to GI complaints. ᮀ Migraine, headache, gastrointestinal complaints, epidemiology, HUNT Anne Hege Aamodt, MD, Norwegian National Headache Centre, Trondheim University Hospital, Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, N-7006 Trondheim, Norway. Tel. + 47 7257 6006, fax + 47 7257 5773, e-mail firstname.lastname@example.org Received 20 October 2006, accepted 12 July 2007
Both headaches and gastrointestinal (GI) symptoms such as nausea, acid regurgitation, diarrhoea and constipation are common in the general population and account for substantial healthcare utilization. However, the scientiﬁc literature about the comorbidity of headache and GI complaints is scant (1). Population-based studies have shown positive associations between migraine and irritable bowel syndrome (IBS) (2), colitis and peptic ulcer (3). However, in one study migraine has been associated with peptic ulcer only among smokers (4). Although a pathogenic role for Helicobacter pylori (Hp) infection in migraine has been suggested (5), most studies have not demonstrated any association between Hp infection and migraine (6, 7).
Coeliac disease has also been linked with migraine (8), but it remains to be conﬁrmed by larger epidemiological studies. Clinic-based studies have demonstrated a higher prevalence of gastro-oesophageal reﬂux (9) and idiopathic dyspepsia (10) among migraineurs. However, in a recent clinic-based study on patients with dyspepsia referred for upper GI endoscopy, migraine prevalence was lower among patients with reﬂux-like/ulcer-like dyspepsia and higher only among those with dysmotility-like dyspepsia or nausea/vomiting (11). Furthermore, upper endoscopy and oesophageal pH monitoring in migraineurs have shown a low prevalence of abnormal ﬁndings (11, 12). As regards a possible association between nonmigrainous headache and GI symptoms, hardly any
© Blackwell Publishing Ltd Cephalalgia, 2007, 28, 144–151
Gastrointestinal complaints Q1 included questions about different GI symptoms such as: ‘have you suffered from nausea during the last 12 months?’. prognosis and choice of therapy (3).Comorbidity of headache and GI symptoms reports are available. (iii) during headache. 2007. 7–14 days/month and >14 days/month. were administered to the participants. Potential confounders such as gender. they were classiﬁed into two groups of either migraine or non-migrainous headache. cardiovascular medication. The Q1 included questions about GI complaints and the Q2 included 13 questions about headache (13). anxiety. 45 453 (88. or (b) photophobia and/or phonophobia. The target population. 145 Methods Study population All inhabitants aged Ն20 years in Nord-Trøndelag County in Norway were invited to participate in the Nord-Trøndelag Health Study between 1995 and 1997 (‘Helseundersøkelsen i Nord-Trøndelag’ = HUNT). © Blackwell Publishing Ltd Cephalalgia. (b) unilateral location. duration of education (Յ9 years. (ii) headache with at least one of the following three characteristics: (a) pulsating quality. and the subjects were asked to rate the intensity of these symptoms as ‘no’. has been described in detail previously (13). and the second (Q2) was ﬁlled in after a medical examination. vitamins. Heartburn and acid regurgitation are the cardinal symptoms of gastro-oesophageal reﬂux disease (16). diarrhoea and constipation. ﬁsh oil or other medicines) and how many months they had used it. cross-sectional health study. or (c) aggravation by physical activity. antasthmatics. Further knowledge about associations between headaches and GI complaints is important. 144–151 . The ﬁrst questionnaire (Q1) was enclosed with the invitation letter. The aim of the present study was to investigate possible associations between GI complaints and headache in a large-scale. These questions were mainly designed to determine whether the person suffered from headache or not. The interaction coefficients were tested using Wald test statistics. ‘some’ or ‘much’. antidepressants. Medication use was based on questions in Q2: ‘Have you taken any medication daily or almost daily during the last 12 months?’ Those who answered ‘yes’ were asked about type of medication (analgesics. 64 560 (70%) participated. including participants and non-participants. sleep medications. Two questionnaires. Of these 51 383 individuals. at least one of the following symptoms: (a) nausea. Based on data from the subsequent 12 headache questions.5%) completed at least one question about GI complaints and 43 782 (85. iron supplement. The diagnoses were mutually exclusive. population-based. depression. Based on a question about headache frequency during the last year. and medication use were adjusted for. to determine frequency of headache and to diagnose migraine according to a modiﬁed version of the migraine criteria of the Headache Classiﬁcation Committee of the International Headache Society (1988) (14). The HUNT study was approved by the Regional Committee for Medical Research Ethics and by the Norwegian Data Inspectorate. tranquillizer. of the 92 566 eligible individuals. headache frequency was divided in three categories: <7 days/month. 28. Persons were classiﬁed as migraineurs if they reported having migraine or fulﬁlled the following three criteria: (i) headache attacks lasting 4–72 h (<4 h was accepted for those who reported visual disturbances often before headache). Statistical analysis The association between headache and GI complaints was estimated using multiple logistic regression with odds ratio (OR) and 95% conﬁdence intervals (CI). including >200 health-related questions. 10–12 years and Ն12 years). Brieﬂy. Headaches that did not fulﬁl the criteria for migraine were classiﬁed as non-migrainous headache. age (10-year categories). The same kind of question was also asked about heartburn/acid regurgitation (reﬂux symptoms). Anxiety and depression were assessed by The Hospital Anxiety and Depression Scale (HADS) Headache diagnoses Subjects who answered ‘yes’ to the question ‘Have you suffered from headache during the last 12 months? ‘were classiﬁed as headache sufferers (13). as comorbidity may alter the clinical course of the disorder and the chance of correct diagnosis by affecting the time of detection. The classiﬁcation of the subjects has been described in detail previously and has been validated by interview diagnoses (15).2%) completed all the questions about GI complaints. A total of 51 383 subjects completed the headache questionnaire Q2 and constituted the ‘head-HUNT’ study.
7% and 18.6%). much reﬂux 2.2 Headache-free (n = 31 541) 46.9% and 8.2 35.2 (15.9). 70 One-year headache prevalence (%) 60 50 40 30 20 10 0 20-29 30-39 40-49 50-59 60-69 ≥70 Age groups much reflux some reflux no reflux Figure 1 One-year prevalence of headache (%) related to age in those with no. There were more women than men in the headache groups compared with headache-free individuals.2 Migraine (n = 6209) 71. whereas reﬂux and diarrhoea were more equally distributed among men and women (reﬂux.146 AH Aamodt et al. OR for non-migrainous headache among men with some reﬂux 1.4.5 (1. and diarrhoea 16. 2007.5) 11. evaluating the probability of a linear relationship between headache frequency and reﬂux symptoms. the results in the multivariate analyses are shown for men and women together as there were no major gender differences. diarrhoea. Chicago. e.6%. and much reﬂux symptoms. 33. respectively. there were linear trends (P < 0. Other variables such as alcohol consumption.0 47. USA). 144–151 .8 52. There were also slight differences in the educational level between the groups. 2. 1. 2. female (%) Mean age (SD) Years of education (%) Ն13 10–12 Յ9 (17–19).8 41.6.0 (1. The ORs for the association between levels of headache frequency and different GI symptoms were performed for each headache diagnosis (migraine and non-migrainous headache) separately where headache-free individuals were used as the reference group. reﬂux was the most common in both genders. educational level. As shown in Fig.9 44. The corresponding ORs for women were 1. some.9% and 17. There was signiﬁcant interaction by gender regarding non-migrainous headache for all GI complaints. the GI complaints were treated as single ordinal variables (categories 1.2) 11.6) and 1. respectively.0 (13.05. smoking and body mass index (BMI) were also evaluated as potential confounders. headache frequency categories were incorporated in a test for trend.5 Characteristics Sex.0 (SPSS Inc. IL. version 13. ‘much’) and were incorporated in a test for trend (approximately a c2 statistic with one degree of freedom) in the logistic analyses to evaluate the probability of a linear relationship between degree of GI complaints and headache (‘dose–response relation’). age.2 46. When appropriate.0%) than in men (respectively.8.g. constipation and nausea. and this was most pronounced for those with migraine. The mean age was higher in the group of headache-free individuals compared with the groups with migraine or non-migrainous headache. However.5. Differences between means were tested with one-way ANOVA and between categories with c2 test. 1. and 3. anxiety and depression.0001) of increasing prevalence of headache (both migraine and non-migrainous headache) with © Blackwell Publishing Ltd Cephalalgia. Among the GI symptoms. After adjusting for gender. ‘no’.3).8). age and educational level in the different diagnostic groups Non-migrainous headache (n = 13 633) 62. Table 1 Distribution of sex. ‘some’.7 (95% CI 1. 28. Results Table 1 presents the demographic data for the different headache groups.3% and 29.2%)..3 44. higher headache prevalence was found in all age groups among those with much reﬂux symptoms compared with those with some or no such complaints (unadjusted analyses). 1.7 (17. Likewise. with higher ORs for non-migrainous headache in men than women. 13. Constipation and nausea were more prevalent in women (respectively. Data analysis was performed with the Statistical Package for the Social Sciences.4 53. 1. medication use. The trend test was considered statistically signiﬁcant at P < 0.8) 13.7 (1.5 42. 30.
5 (1.3. 188.8.131.52) 1.7 (95% CI 5.0001) of higher prevalence ORs for all the GI complaints with increasing headache frequency (Table 3).8) among individuals with ‘much’ nausea compared with those without nausea (Table 2).4 (1.8.5 (1. 3. 2. 2007.0.2 (2.Comorbidity of headache and GI symptoms Table 2 Prevalence odds ratio (OR) of headache (dependent variable) among different groups with gastrointestinal complaints. 1.6. 144–151 Discussion In this large-scale. 1.3. 1. diarrhoea and constipation was increased more than two times for those with headache >14 days/ month compared with those without headache. diarrhoea. 3. 1.5 (95% CI 2. 1.5 (1.2 (1. cross-sectional study we found higher prevalence of headache in individuals with much reﬂux symptoms.0) 1.5) 1.8 (1. OR* (95% CI) Migraine (n = 6209) No. education.4 (1. The associations between headache and GI symptoms were reduced after adjustment for potential confounding by medication use.5. 2. other GI symptoms have not been validated and no further GI investigations were performed. However. For example. 1. 2. The OR for each of the symptoms reﬂux.9) 1.4. one would expect that functional GI disorders.6.9 (1.0) 1. 2.7.2 (1.1.5) for migraine and 4.0001 for all the variables.3.0 1. The corresponding OR was 2. 184.108.40.206.7 (1. 1.3 (1.4) 1. © Blackwell Publishing Ltd Cephalalgia.7) for non-migrainous headache compared with those without headache.6) 1. increasing intensity of GI symptoms. 95% CI 2. 1.6) 1.2 (3. 1.6.8) 1.8) 1.0 3.6) 1.5) 1.7) 1.5.8) 1. population-based.6) *Odds ratio adjusted for sex.0 220.127.116.11 (1.8 (1. 3.8) 2. age and education. However.7 (1. 1. anxiety or depression.6) 2. This was most clearly demonstrated for nausea. there are several limitations to the study.4.1.0 1. 3.4) 1.1.4) 1.2.8) 3566 1763 441 439 4213 1175 191 630 3928 1368 351 630 4014 1431 153 611 1. 2. 2. 2. 2.6 (1. OR* (95% CI) 147 Variables Total number Non-migrainous headache (n = 13 633) No.3 (1. 2.8 (1.1. age.0 1.4 (2. Not all individuals answered all questions All headache types (n = 19 842) No.4.7) 1.6. OR* (95% CI) Reﬂux symptoms No 32 312 Some 12 215 Much 2 519 Missing 4 337 Diarrhoea No 37 692 Some 6 839 Much 922 Missing 5 930 Constipation No 35 729 Some 8 618 Much 1 936 Missing 5 930 Nausea No 39 312 Some 5 579 Much 587 Missing 5 905 11 201 5 630 1 356 1 655 13 397 3 593 563 2 289 12 587 4 139 1 074 2 289 13 476 3 717 405 2 244 1.0 1.5-1. so the reported complaints may have represented different disorders. 1.4 (2. 1.4 (2.0 2.6.0 1.1 (1.0.8) after adjusting for all the covariates. there were strong linear trends (P < 0.8 (95% CI 4.6 (1. 1. First.4) 3.6 (1.6 (1. In addition. being very prevalent in . 1.4. 1. 1. 1.4 (1. The strengths of the study were the large and unselected population and the use of validated headache diagnoses.8) 1. 3.7. 1.7) 1.4) after adjustment for only sex. depression. 22).4 (1.0 (95% CI 2.8 (1.0) 1.7 (1.8) 1.5) 1.6.0 1.0) 1.9. P-trend value <0. 28.0 1. 1.0 1. There were no major differences between migraine and non-migrainous headache regarding the association with GI complaints.2.1) 1.2. 1.5 (1.4.8 (1. anxiety and use of medication calculated in multiple logistic regression.3.5) 7635 3867 915 1216 9184 2418 372 1659 8659 2771 723 1659 9462 2286 252 1633 1.4 (1.6) 1.6) 1. 18.104.22.168. the OR for all headache types in much diarrhoea was 3.6) 1.1) after adjustment for medication use in addition and 2. constipation or nausea than in those without such complaints. 2.7 (95% CI 2.2) 1. 2. The association between headache and GI complaints increased markedly with increasing headache frequency. 1.7.6. headache being more than three times more likely (OR 3.7) 2.0 1. For nausea the corresponding OR values were 6.9) 2.8 (1. The question on acid regurgitation/heartburn (reﬂux) has also been validated (20) and the use of questionnaires to assess these symptoms is well validated as a reliable measurement of the true occurrence of reﬂux (21.7 (1.8 (1. 1.
3) 2. 2. The fact that headache and GI complaints were among many other objectives of HUNT makes selective participation due to headache or GI complaints unlikely.6) Constipation (n = 46 283) No. 2. making the two groups more similar than they really were.2 (2. 28.1. 5711 3560 873 410 1094 380 131 2466 493 279 OR* (95% CI) 1. 3. 2.2 (3.7) Headache-free 32 965 All headache types <7 days/month 14 500 7–14 days/month 2 729 >14 days/month 1 189 Migraine <7 days/month 4 361 7–14 days/month 1 125 >14 days/month 350 Non-migrainous headache <7 days/month 10 139 7–14 days/month 1 604 >14 days/month 839 *Odds ratio adjusted for sex.6) 5.8. 3.5) 2. ﬁbromyalgia and chronic fatigue syndrome (29–32). This is not surprising.0.) 1. 2. The bias caused by misclassiﬁcation can either exaggerate or underestimate the true differences between headache groups. The GI symptoms investigated in this study seem to be approximately as common among persons with non-migrainous headache as among migraine sufferers.8) 2.2 (1. which was more prevalent among migraineurs (Table 3).0 (1. 2.7) 1. Our results seem to be in accordance with previous population-based and clinic-based studies concerning comorbidity of migraine and GI conditions (2. 2. 9.1.7) 2.4 (1. 3806 2973 669 313 921 280 106 2052 389 207 OR* (95% CI) 1.7) 4.0.8) 2.5. 2. 1.5. the questionnaire-based headache diagnoses were not optimal compared with the interview diagnoses (15). depression.6.4) 2.7. 2.8.5) 1.8. Furthermore.0.8 (1.9.1 (1.0) 3.9.2.) 2. 3.3) 1. In addition. 6.9) 2. The impact of nonparticipants has been discussed in more detail previously (13).7 (1. 2.2 (4. 3.8.1) 1. 2. 2007. 4.9 (3. P-trend value <0.0.7.8 (1.7 (1. age.6) 2.5. 1. 144–151 .8. 2. anxiety and use of medication calculated in multiple logistic regression. 1. headache frequency seems to have had a greater impact on the association with GI complaints than the headache diagnoses. the general population. 5. which has previously been linked to both headache and GI © Blackwell Publishing Ltd Cephalalgia. 11). 2.8. 35).8 (1.7) 2. 2.4 (3. education.9. Since the study is cross-sectional it cannot be determined whether frequent headache causes GI complaints or whether other risk factors or a shared susceptibility causes this association.6 (1. 8215 4886 1116 517 1450 469 165 3436 647 352 OR* (95% CI) 1.5. which may suggest that headache sufferers generally are predisposed to other pain syndromes and somatic complaints (33).6) 2.2 (1.2 (2. 4.7 (5.1 (1.7 (2. Table 3 Prevalence odds ratio (OR) of different gastrointestinal complaints (dependent variables) related to headache frequency and compared with headache-free subjects Reﬂux symptoms (n = 47 046) Variables Total No. 8. 36).5) 2. 1. as nausea is among the diagnostic criteria for migraine.4) 2.6 (4. An exception was nausea.0 (ref. Information bias should be considered as an explanation for the ﬁndings in the present study.4) Nausea (n = 45 478) No. the prevalence of migraine in the current population is consistent with data from other population-based studies in Western countries (23).3) 2.0 (ref. 2.7.8) 4.0.8) 2.0 (ref.2 (1.148 AH Aamodt et al. 9–11).3 (2.) 1. 1. 1.2.5. In studies on self-reported complaints the results may be inﬂuenced by a tendency to report different symptoms in some individuals (34.9.0 (ref. 2. In the present study. 1. 3.4) 2.3) 1.3 (2.5) 4.0.8) 2.5) 2. The gastrointestinal symptoms were considered to be present if there were some or many of the symptoms.7.6 (2.7 (2.7 (1. Furthermore. the ﬁndings in the present study were in line with other studies using different methods (2. Autonomic nervous system (ANS) dysfunction.3 (2. 2. headache has been reported as a signiﬁcantly more frequent symptom in various unexplained clinical conditions such as IBS. are responsible for the described GI symptoms among the majority.0. 2. the prevalence of GI symptoms in the current population is comparable to that found in other studies (24–28).6.9.) 1.1 (1.0 (1. 2. due to diagnostic inaccuracy. This may create strong associations that are explained by personality traits rather than by biological mechanisms (34.4) Diarrhoea (n = 45 453) No. However.3 (2.0) 2.4 (1.5) 1.9) 2. 3. 5. 2262 2719 795 390 1013 375 144 1706 420 246 OR* (95% CI) 1. there were migraine patients in the group of non-migraineurs and vice versa. Most likely.4 (2. 1.8 (4.0.6) 3.0001 for all the variables. Furthermore.6.8 (1.0.6 (1. Those who report their headache complaints might be more likely to report other complaints such as GI symptoms.3) 6.
3rd edn. 2007. 55). Bortoli A. Vatten L. 1994:301–14. 25:136–40. Portincasa P et al. editor. 10 Kurth T. 8 Gabrielli M. dysregulation of the ANS. 6 Pinessi L. Headache 1996. 4 Chen TC. 40:836–9. Beneﬁcial effects of Helicobacter pylori eradication on migraine. Rainero I. Ricchetti G. BMJ 1992. 28. but also by the comorbid conditions. Addolorato G. The inﬂuence of smoking on observed associations. Headache 2000. Migraine comorbidity. there were completely normal endoscopic ﬁndings in 90% of migraineurs with nausea/ vomiting or other dysmotility-like symptoms. Fiore G. Di Massimo C. have demonstrated autonomic dysfunction in migraineurs during headache-free intervals. De Luca A. Edelstein S. Cerrato C et al. Franceschi F. The strength of the associations between headache and GI complaints was gently reduced after adjusting for medication use (54. 2006:243–9. Goadsby PJ. one cannot exclude the possibility that if more extensive data about medication use and psychological factors had been available. It is important to consider the total burden of discomfort in these patients in order to provide for the best treatment. Radaelli F. as both are strongly associated with anxiety and depression (50–53). Ellenberg JH. Prada A. Fenton BT. Gambrielli M. Stovner LJ. Prevalence of migraine and non-migrainous headache— head-HUNT. Comorbidity of migraine with somatic disorders in a large-scale epidemiologic study in the United States. the strength of association would have been even more attenuated after adjustment. Ramadan NM. Rasmussen BK. Holtmann G. editors. Cremonini F. and the prognosis as to overall function may be determined not only by headache. Cephalalgia 2000. References 1 Merikangas KR. 98:625–9. or. Verdal. 9 Featherstone HJ. psychological factors may also be a common denominator for headache and GI symptoms. Cephalalgia 2002. Cephalalgia 2006. Lydeard S. Norwegian Institute of Public Health.. In the study of Meucci et al. Savi L. Helicobacter pylori infection and migraine. 12 Centonze V. Faculty of Medicine. Carolei A. Zwart JA. 7 Ciancarelli I. Bovim G. © Blackwell Publishing Ltd Cephalalgia. The GI symptoms may also represent side-effects caused by medicines against headache. The headaches. that the GI complaints represent manifestations of the GI component of migraine. 5 Gasbarrini A. as well as during migraine attacks (42). 36:442–5.Comorbidity of headache and GI symptoms complaints. 11 Meucci G. the observed association between GI complaints and chronic headache may have clinical implications. 3 Merikangas KR. 45–49). New York: Raven Press. Irritable bowel syndrome in the general population. Polito BM. Chronic Helicobacter pylori infection and migraine: a case–control study. . 44:1024–8. Tfelt-Hansen P. 37:622–5. In: Olesen J. 304:87–90. and various GI symptoms are common side-effects of NSAIDs. Neufang-Hüber J. Furthermore. 47. Arch Neurol 1987. Headache 1985. Medical diagnoses and problems in individuals with recurrent idiopathic headache. Headache classiﬁcation and epidemiology. Diener HC. In disorders such as IBS and functional dyspepsia psycho-social factors. Several studies. Marini C. 45:765–70. Welch KMA. Padalino C. Leviton A. Norwegian University of Science and Technology (NTNU). Prevalence of unexplained upper abdominal symptoms in patients with migraine. Fiore G. In conclusion. and their symptoms were considered related to their migraine attacks and not to any GI disorder (11). 144–151 149 Acknowledgements The Nord-Trøndelag Health Study (The HUNT Study) is a collaboration between HUNT Research Centre. PA: Lippincott Williams & Wilkins. Endoscopy 2005. a large population-based study. Associations between migraine and celiac disease: results from a preliminary case–control and therapeutic study. Low NCD. and Nord-Trøndelag County Council. 13 Hagen K. De Matteis G. Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for openaccess upper gastrointestinal endoscopy. The association between headache and GI symptoms may also be related to interactions between the nociceptive system and the ANS. Ojetti V et al. Doronzo F. Candelli M et al. Cassiano MA. 22:222–5. Valfrè W. Migraine and other diseases in women of reproductive age. and depression (assessed by HADS) in the multivariate analyses. The dyspeptic syndrome in migraine: morphofunctional evaluation on 53 patients. might be a common mechanism (37–43). Crotta S. Other possible explanations might be that GI complaints lead to headache. It is well known that opioid analgesics may cause constipation and nausea. chap. vice versa. 2 Jones R. Gerken G. Tozzi-ciancarelli MG. 20:900–6. Gentil S et al. Philadelphia. anxiety. However. altered intestinal motility and increased visceral sensitivity have been demonstrated. 26:506–10. Ltd. Pellicano R. In: Olesen J. mostly clinic based. There is anatomical and functional evidence of convergence between nociceptive and viscerosensory systems involved in reﬂexes and homeostatic and behavioural control of autonomic outﬂow (44). Hepatogastroenterology 1998. Am J Gastroenterol 2003. The latter is thought to result from dysregulation of the bidirectional communication between the gut with its enteric nervous system and the central nervous system—the brain–gut axis (37–40. Further research about the aetiology of association of headache and GI complaints is needed.
incidence. Holtmann G. 19 Bjelland I. Bergmark M. 9:527–33. Cortelli P. case–control study. The validity of the Hospital Anxiety and Depression Scale. 13:333–45. 179:540–4. Hagen K. 17:563– 74. 12:2442–51. Gotthard R. Carlsson R. A new questionnaire for gastroesophageal reﬂux disease. Jarrett M. Potentials and pitfalls in analytical headache epidemiological studies—lessons to be learned from the Head-HUNT Study. Bond EF. Garner M et al. 29 Whitehead WE. Ihlebaek C. Dig Dis Sci 2002. Talley NJ. Aliment Pharmacol Ther 2004. 20:1195–203. Am J Gastroenterol 2004. Shechter A. 144–151 . Johnsen R. Wilhelmsen I. Pierangeli G. 44:53–64. 58:422–7. Bovim G. Snaith RP. Castell DO. Chronic diffuse musculoskeletal 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 © Blackwell Publishing Ltd Cephalalgia. Heslop P. Mulak A. Lipton RB. Cephalalgia 1988. Kindt S. Urbain D. Lagergren J. Heitkemper M. Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability. A population-based study on bowel habits in a Swedish community: prevalence of faecal incontinence and constipation. 30 Aaron LA. Carroll D. Irritable bowel syndrome: a model of 14 Headache Classiﬁcation Committee of the International Headache Society. Pascual J. impact on daily life. and utilization of medical resources. Jones KR. Headache 2004. Singh S. 22 Shaw MJ. Rockwood T. 25 Louis E. Prevalence of irritable bowel syndrome: a community survey. Cephalalgia 2000. Zwart JA. Initial validation of a diagnostic questionnaire for gastroesophageal reﬂux disease. Adlis S et al. 27:403–13. Nos P. 69:539–47. Baillieres Best Pract Res Clin Gastroenterol 2004. [Bias from dependent errors in observational studies]. Zwart J-A. 37:911– 16. BMJ 2002. 28. Svebak S. Tidsskr Nor Laegeforen 2005. Svebak S. Einarsen C. 18:707–16. Talley NJ. Ursin H. Pelckmans P et al. Neckelmann D. Mesquita MA. Bovim G. Levy LR. 33:464–71. Feld AD. item analyses and internal consistency in a large population. Updated guidelines for the diagnosis and treatment of gastroesophageal reﬂux disease. 24 (Suppl. Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome. Bridge P. Acta Psychiatr Scand 1983. 125:173–5. Am J Gastroenterol 2001. Zwart JA. Roalfe A. Hagen K. Scand J Gastroenterol 1994. 2):68–70. Epidemiology of upper dyspepsia in a random population. Lee KJ. Macleod J. 52:69– 77. Weaver AL. 55:12–22. 290:66–72. An updated literature review. J Psychosom Res 2002. 54:490–1. Ye W. Rhee PL. Hospital Anxiety and Depression (HAD) scale: factor structure. Walker LS. 29:1–6. cranial neuralgias and facial pain. Hiele M. 26 Wilson S. Migraine: a chronic sympathetic nervous system disorder. Dahl AA. Haug TT. 27 Garrigues V. Son HJ. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Jockenhoevel F. Almeida J. Wilhelmsen I. Talley NJ. Galvez C. Haug TT. Sjödahl R. Palsson O. Stovner LJ. 100:190–200. 122:1140–56. Stovner L. 15 Hagen K. Haug TT. Eur J Gastroenterol Hepatol 2002. Eur J Neurol 2006. DeLooze D. Svebak S. Br J Gen Pract 2004. Neurol Sci 2003. Lustyk MK. JAMA 2003. Br J Psychiatry 2001. Scand J Gastroenterol 2002. Kim YH. Mayo Clin Proc 1994. Silberstein SD. The hospital anxiety and depression scale. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported deﬁnition in a population-based survey in Spain. Obesity and estrogen as risk factors for gastroesophageal reﬂux symptoms. Dig Liver Dis 2001. Best Pract Res Clin Rheumatol 2003. and risk factors. Olafsen K. Psychosom Med 1993. Ponce M. 67:361–70. 43:2093–8. Deprez P. 324:1247–51. Zinsmeister AR. 20:244–51. Berstad A. Hallböök O. The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Hagen K. Eur J Neurol 2002. 23 Stovner LJ. 20 Nilsson M. Peroutka SJ. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Role of autonomic dysfunction in patients with functional dyspepsia. 7):1–96. Farup PG. Epidemiology of headache in Europe. 17 Zigmond AS. Vandvik PO. Head HUNT: validity and reliability of a headache questionnaire in a large population-based study in Norway. Jorgensen T. Neurology 2002. Heartburn in Belgium: prevalence. Buchwald D. 47:27–31. Bonaz B. Hausken T. Stordal E. 8 (Suppl. Low vagal tone and antral dysmotility in patients with functional dyspepsia. 24 Kay L. Kristensen P. 16 DeVault KR. 2007. pain. Stewart WF. 18 Mykletun A. Pettersson E et al. Davey Smith G. Pathophysiology of functional dyspepsia. Chronic pain–autonomic interactions. Migraine and autonomic nervous system function: a population-based. 21 Locke GR. 14:279–84. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Am J Gastroenterol 2005. Psychological stress and cardiovascular disease: empirical demonstration of bias in a prospective observational study of Scottish men. Hertig V. Ponce J. natural history. Kim JJ et al. Burr RL. Ortiz V. ﬁbromyalgia and co-morbid unexplained clinical conditions. Figueiredo J. Dig Dis Sci 1998. Gut 1998. Prevalence. 56:181–6. 28 Walter S. Metcalfe C. Dahl AA. Classiﬁcation and diagnostic criteria for headache disorders. Cephalalgia 2007. Von Korff M. Beebe TJ. Roberts L. Terwindt G. Zwart JA. Sung IK. Psychosom Med 1994. Goebell H. Tack J. Am J Epidemiol 2004.150 AH Aamodt et al. 42:501–6. Lorena S. Hart C. 96:52–7. Park DI. Whitehead WE. Hausken T. Wilhelmsen I. 159:520–6. Vatten L. Hveem K. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia.
Dahl AA. Mach T. anxiety. Bovim G et al. The brain–gut axis in irritable bowel syndrome? Clinical aspects. 62 (Suppl. Hagen K. 10:125–31. J Clin Psychiatry 2001. © Blackwell Publishing Ltd Cephalalgia. 37:294–8. CNS Spectr 2003. Depression. 2007.Comorbidity of headache and GI symptoms the brain–gut interactions. Dahl AA. Naliboff BD. Neurology 2004. Analgesic overuse among subjects with headache. Zwart JA. and the gastrointestinal system. Crema F. and low-back pain. 10:147–52. 28. Svebak S. Hagen K. Dyb G. Eur J Neurol 2003. Frigo G. Triptans and gastric accommodation: pharmacological and therapeutic aspects. 62:1540–4. Holmen J. De Ponti F. The comorbidity of migraine. 61:160–4. Dig Liver Dis 2004. Moro E. Med Sci Monit 2004. Stovner LJ. 53 Mayer EA. Low NC. 36:85–92. The Nord-Trøndelag Health Study. Dyb G. Neurology 2003. Craske M. neck. 54 Zwart JA. 10:55– 62. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Holmen J. Odegard KJ. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol 2002. 8:433–44. Med Sci Monit 2004. Mykletun A. Dyb G. 55 Zwart JA. 8):28–36. Svebak S. 151 48 49 50 51 52 Haug TT. Hagen K. Depression and anxiety disorders associated with headache frequency. 144–151 . Merikangas KR.
This action might not be possible to undo. Are you sure you want to continue?